CTCBIO Inc. (KOSDAQ:060590)
6,890.00
-70.00 (-1.01%)
At close: Mar 28, 2025, 3:30 PM KST
CTCBIO Revenue
In the year 2024, CTCBIO had annual revenue of 144.41B KRW with 4.74% growth. CTCBIO had revenue of 40.60B in the quarter ending December 31, 2024, with 15.53% growth.
Revenue
144.41B
Revenue Growth
+4.74%
P/S Ratio
1.14
Revenue / Employee
579.95M
Employees
249
Market Cap
164.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 144.41B | 6.53B | 4.74% |
Dec 31, 2023 | 137.88B | -27.33B | -16.54% |
Dec 31, 2022 | 165.21B | 24.89B | 17.74% |
Dec 31, 2021 | 140.32B | 10.29B | 7.91% |
Dec 31, 2020 | 130.03B | -6.09B | -4.48% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 66.19T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,547.32B |
Hyundai Motor Company | 175.23T |
Kia Corporation | 107.45T |
Celltrion | 3,557.30B |
KB Financial Group | 15.01T |